Avantec Vascular Chooses bioaccess™ for a First-In-Human Clinical Study in Latin America

Avantec Vascular Corporation (https://www.avantecvascular.com/), a company in the San Francisco Bay Area dedicated to advancing vascular therapies through innovation, has chosen Latin America as the destination for the first-in-human study of an innovative vascular device. bioaccess™ will help Avantec Vascular with the selection of a principal investigator, the submission of its regulatory dossier for the ministry of health approvals, and other activities related to carrying out the study.

Clinical TrialsJulio G. Martinez-ClarkSeptember 3, 2021latin america, Colombia, MEXICO, first-in-human, clinical study, avantec vascularComment

Welwaze Chooses bioaccess™ to Access the Colombian Medical Device Market with its Celbrea® Product

Welwaze Medical Inc., the manufacturer of the innovative Celbrea® medical device for the detection of early signs of breast disease, has decided to enter the Latin American market and through its master distributor in Latin America, has chosen bioaccess™ as its regulatory and market access consulting firm to aid it in entering the Colombian market.

Ambiance Ventures™ and bioaccess™ Enter into Cooperation Agreement for their Commercialization Services in Latin America

Ambiance Ventures™ ("AV"), a Division of Nadkarni Media Group LLC, a Pennsylvania based advisory company specialized in managing corporate innovation and business development programs for life science companies; and bioaccess™- a Colombia and Florida based clinical research and regulatory services company, are pleased to announce a cooperation agreement for licensing innovative medical products, clinical trials regulatory processing, and marketing/distribution in Latin America.

IMH Assets Corp., dba bioaccess™ | 1200 Brickell Avenue, Suite 1950 #1034, Miami, FL 33131 | 166 Geary St. 15th FL #1181, San Francisco, CA 94108

CALL or TEXT US: +1 (407) 205-8930‬ | EMAIL US | BOOK A MEETING